The largest blog for reading the latest medical research on all disease, the prevention and its treatment . Pulled from variety of sources

Friday, March 31, 2017

High-dose vitamin C makes cancer treatment more effective, trial shows according to : Medical News Today

How vitamin C weakens cancer cellsThe mechanism that might explain the potential efficacy of vitamin C in treating lung and brain cancer relates to the cancer cells' metabolism. More recent studies have examined the combined effect of high-dose vitamin C and conventional cancer treatment. A new clinical trial shows that a high dose of vitamin C can improve health outcomes for patients who are undergoing conventional cancer treatment. However, a new clinical trial tests the effect of high-dose vitamin C in combination with standard treatment on health outcomes for patients with cancer. To put this into perspective, 9 months of intravenous vitamin C treatment as part of the phase II trial currently costs less than one dose of chemotherapy.



High-dose vitamin C makes cancer treatment more effective, trial shows
Mega doses of vitamin C could help patients being treated for cancer. The next step is to looking at whether high dose vitamin C improves patients' lifespan and quality of life while undergoing cancer treatments. Scientists say this does not mean vitamin C is a cure for cancer, but it may improve how patients respond to chemotherapy and radiation. New research shows regular infusions of concentrated vitamin C damaged brain cancer cells without harming healthy ones. A cancer therapy, which was rejected in the 1970s, is getting a second chance thanks to researchers from the University of Iowa.

Large vitamin C doses can extend brain cancer patients' lives by six months, experts reveal

Getty Images 2 Study shows vitamin C doses can extend brain cancer patients' livesUS experts found it had the ability to sensitise cancer cells to radiation and chemotherapy. This high dose was necessary because vitamin C has a half-life of about two hours in the circulation of humans. The big doses were not toxic to normal cells and only caused minor side effects, like a dry mouth and frequent loo trips. Co-senior author Assistant Professor Dr Bryan Allen said: "The majority of cancer patients we work with are excited to participate in clinical trials that could benefit future patient outcomes down the line." "Results look promising." Survival rates increased to between 18 and 22 months versus the normal 14 to 16 months.


collected by :Lucy William

To follow all the new news about Disease !!! All you need to know about all kinds of diseases

No comments:

Post a Comment